Search results
Ozempic Patients Are Switching to These Less Expensive Weight-Loss Drugs — Best Life
Best Life· 1 day agoThe semaglutide injection is approved to treat Type 2 diabetes, but its off-label use as a chronic...
Senators blame sky-high drug prices on abuse of the patent system
NBC NEWS· 3 days agoThe patent system is meant to reward innovation by allowing drugmakers to exclusively sell new...
Amphastar maintains stock target on AMP-008 FDA approval By Investing.com
Investing.com· 1 day agoThe product, which is a generic version of Teva's ProAir HFA (albuterol sulfate inhalation aerosol),...
FDA Approves Biosimilars for Macular Degeneration Treatment
Healthline via AOL· 2 days agoThe FDA approved two interchangeable biosimilars to treat macular degeneration. The biosimilars work...
How Drug Companies Stifle Competition With ‘Product Hopping’
Forbes· 4 days agoActavis had spent that sum to acquire Forest and its portfolio of pharmaceutical products. Forest...
Hims & Hers is getting into the weight-loss drug game — and Wall Street is loving it
INSIDER via Yahoo News· 4 days agoThat's way cheaper than competitors. The list prices for Ozempic and Wegovy are $935.77...
Congress evaluate how to lower prescription prices by increasing competition
WPXI via Yahoo News· 3 days agoMedical experts say competition is key. They say big pharma has a limited period to sell a new drug...
Here's Why You Should Retain Walgreens Boots (WBA) For Now
Zacks via Yahoo Finance· 1 day agoRevenues of $511 million increased 17.7% from last year’s comparable figure. You can see the...
McKesson (MCK) Hits 52-Week High: What's Driving the Stock?
Zacks via Yahoo Finance· 3 days agoStiff Competition...distribution, third-party logistics companies and large-payer organizations....
This Unpopular Dividend Stock Is a Buy
Motley Fool via Yahoo Finance· 1 day agoYes, the drugmaker is going through a rough patch with slower-than-expected new drug sales, an upcoming patent cliff, and a growing need to deleverage...
